Catherine Fiess

Circulating DNA as a Strong Multimarker Prognostic Tool for Metastatic Colorectal Cancer Patient Management Care

Safia El Messaoudi, Florent Moulière, Stanislas du Manoir et al. · Clinical Cancer Research · 2016 · 165 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Clinical utility of circulating DNA analysis for rapid detection of actionable mutations to select metastatic colorectal patients for anti-EGFR treatment

Alain R. Thierry, Safia El Messaoudi, Caroline Mollévi et al. · Annals of Oncology · 2017 · 114 citations

Medicine, Molecular Biology, Oncology +17

Sequential first-line treatment with nab-paclitaxel/gemcitabine and FOLFIRINOX in metastatic pancreatic adenocarcinoma: GABRINOX phase Ib-II controlled clinical trial

Eric Assénat, Christelle de la Fouchardière, F. Portales et al. · ESMO Open · 2021 · 21 citations · Full text

Medicine, Oncology, Pharmacology +12

Determination of biomarkers associated with neoadjuvant treatment response focusing on colibactin-producing <i>Escherichia coli</i> in patients with mid or low rectal cancer: a prospective clinical study protocol (MICARE)

Christophe Taoum, Guillaume Carrier, Marta Jarlier et al. · BMJ Open · 2022 · 17 citations · Full text

Medicine, Microbiology, Oncology +15

Inter-observer agreement between dermatologists and oncologists in assessing dermatological toxicities in patients with metastatic colorectal cancer treated by cetuximab-based chemotherapies: A pilot comparative study

Jacqueline Duffour, Simon Thézenas, O. Dereure et al. · European Journal of Cancer · 2010 · 16 citations

Medicine, Dermatology, Oncology +17